These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29843056)

  • 41. Mast cells in innate and adaptive immunity to infection.
    Palker TJ; Dong G; Leitner WW
    Eur J Immunol; 2010 Jan; 40(1):13-8. PubMed ID: 20043290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth Infections.
    Shimokawa C; Kanaya T; Hachisuka M; Ishiwata K; Hisaeda H; Kurashima Y; Kiyono H; Yoshimoto T; Kaisho T; Ohno H
    Immunity; 2017 May; 46(5):863-874.e4. PubMed ID: 28514691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
    Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
    [No Abstract]   [Full Text] [Related]  

  • 44. [The role of mast cells in innate immunity in antibacterial defense].
    Brzezińska-Błaszczyk E; Rdzany RS
    Postepy Hig Med Dosw (Online); 2005; 59():544-53. PubMed ID: 16407793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.
    Galli SJ; Grimbaldeston M; Tsai M
    Nat Rev Immunol; 2008 Jun; 8(6):478-86. PubMed ID: 18483499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The innate host response in caries and periodontitis.
    Meyle J; Dommisch H; Groeger S; Giacaman RA; Costalonga M; Herzberg M
    J Clin Periodontol; 2017 Dec; 44(12):1215-1225. PubMed ID: 28727164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses.
    Tkaczyk C; Jensen BM; Iwaki S; Gilfillan AM
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):427-50. PubMed ID: 16931287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
    Heegaard PM; Fang Y; Jungersen G
    Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in mast cell biology: new understanding of heterogeneity and function.
    Moon TC; St Laurent CD; Morris KE; Marcet C; Yoshimura T; Sekar Y; Befus AD
    Mucosal Immunol; 2010 Mar; 3(2):111-28. PubMed ID: 20043008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.
    Dudeck A; Dudeck J; Scholten J; Petzold A; Surianarayanan S; Köhler A; Peschke K; Vöhringer D; Waskow C; Krieg T; Müller W; Waisman A; Hartmann K; Gunzer M; Roers A
    Immunity; 2011 Jun; 34(6):973-84. PubMed ID: 21703544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mast cells and basophils in innate immunity.
    Abraham SN; Arock M
    Semin Immunol; 1998 Oct; 10(5):373-81. PubMed ID: 9799712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effector molecules of the innate immune system for treatment of wound infections].
    Steinsträsser L; Langer S; Lehnhardt M; Steinau HU
    Chirurg; 2007 Apr; 78(4):343-8. PubMed ID: 17377758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mast cells--key effector cells in immune responses.
    Metz M; Maurer M
    Trends Immunol; 2007 May; 28(5):234-41. PubMed ID: 17400512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis.
    Kanamaru Y; Sumiyoshi K; Ushio H; Ogawa H; Okumura K; Nakao A
    J Immunol; 2005 Apr; 174(7):4193-7. PubMed ID: 15778380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation and inhibition of adaptive immune response mediated by mast cells.
    Toniato E; Frydas I; Robuffo I; Ronconi G; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):543-548. PubMed ID: 28952282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.
    St John AL; Chan CY; Staats HF; Leong KW; Abraham SN
    Nat Mater; 2012 Jan; 11(3):250-7. PubMed ID: 22266469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired mast cell-driven immune responses in mice lacking the transcription factor NFATc2.
    Becker M; Heib V; Klein M; Doener F; Bopp T; Taube C; Radsak M; Schild H; Schmitt E; Stassen M
    J Immunol; 2009 May; 182(10):6136-42. PubMed ID: 19414766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulating immunity as a therapy for bacterial infections.
    Hancock RE; Nijnik A; Philpott DJ
    Nat Rev Microbiol; 2012 Mar; 10(4):243-54. PubMed ID: 22421877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.